Article Text

other Versions

PDF
Randomised controlled trial
Respiratory syncytial virus prophylaxis reduces chronic respiratory morbidity in prematurely born infants
  1. Anne Greenough
  1. Division of Asthma, Allergy and Lung Biology, NICU, King's College Hospital, King's College London, London, UK
  1. Correspondence to: Professor Anne Greenough, Division of Asthma, Allergy and Lung Biology, NICU, King's College Hospital, King's College London, Denmark Hill, London, SE5 9RS, UK; anne.greenough{at}kcl.ac.uk

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMedWeb of Science

Context

Respiratory syncytial virus (RSV) and lower respiratory tract infections (LRTIs) are associated with chronic respiratory morbidity (CRM) at follow-up. In infants born very prematurely who had bronchopulmonary dysplasia (BPD), RSV LRTIs were associated with greater lung function abnormalities and healthcare utilisation at school age.1 A prospective study2 demonstrated that among very prematurely born infants (<32 weeks of gestational age) regardless of the BPD status and whether hospitalisation was required, RSV LRTIs were associated with increased CRM and lung function abnormalities at follow-up in infancy. Even among infants born between 32 and 35 weeks of gestation, the mean cost of care …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.